A Hyperoxic Lung Injury Model in Premature Rabbits: The Influence of Different Gestational Ages and Oxygen Concentrations

Carregando...
Imagem de Miniatura
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
MANZANO, Roberta Munhoz
MASCARETTI, Renata Suman
CARRER, Valeria
HADDAD, Luciana Branco
FERNANDES, Aline Rabelo
REYES, Ana M. A.
Citação
PLOS ONE, v.9, n.4, article ID e95844, 8p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Many animal models have been developed to study bronchopulmonary dysplasia (BPD). The preterm rabbit is a low-cost, easy-to-handle model, but it has a high mortality rate in response to the high oxygen concentrations used to induce lung injury. The aim of this study was to compare the mortality rates of two models of hyperoxia-induced lung injury in preterm rabbits. Methods: Pregnant New Zealand white rabbits were subjected to caesarean section on gestational day 28 or 29 (full term = 31 days). The premature rabbits in the 28-day gestation group were exposed to room air or FiO(2) >= 95%, and the rabbits in the 29-day gestation group were exposed to room air or FiO(2) = 80% for 11 days. The mean linear intercept (Lm), internal surface area ( ISA), number of alveoli, septal thickness and proportion of elastic and collagen fibers were quantified. Results: The survival rates in the 29-day groups were improved compared with the 28-day groups. Hyperoxia impaired the normal development of the lung, as demonstrated by an increase in the Lm, the septal thickness and the proportion of elastic fibers. Hyperoxia also decreased the ISA, the number of alveoli and the proportion of collagen fibers in the 28-day oxygen-exposed group compared with the control 28-day group. A reduced number of alveoli was found in the 29-day oxygen exposed animals compared with the control 29-day group. Conclusions: The 29-day preterm rabbits had a reduced mortality rate compared with the 28-day preterm rabbits and maintained a reduction in the alveoli number, which is comparable to BPD in humans.
Palavras-chave
Referências
  1. Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945
  2. Albertine KH, 2013, SEMIN PERINATOL, V37, P60, DOI 10.1053/j.semperi.2013.01.001
  3. Bancalari Eduardo, 2003, Semin Neonatol, V8, P63, DOI 10.1016/S1084-2756(02)00192-6
  4. Bland RD, 2005, AM J RESP CRIT CARE, V172, P899, DOI 10.1164/rccm.200503-3840C
  5. Bland RD, 2003, BIOL NEONATE, V84, P101, DOI 10.1159/000071012
  6. Bland RD, 2003, AM J PHYSIOL-LUNG C, V285, pL76, DOI 10.1152/ajplung.00395.2002
  7. BONIKOS DS, 1975, LAB INVEST, V32, P619
  8. Bremer F, 2012, PLOS ONE, V7
  9. Chang M, 2013, AM J TRANSL RES, V5, P594
  10. Chen YW, 1997, J PEDIATR, V130, P409, DOI 10.1016/S0022-3476(97)70202-6
  11. Chess PR, 2006, SEMIN PERINATOL, V30, P171, DOI 10.1053/j.semperi.2006.05.003
  12. Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8
  13. COALSON JJ, 1995, AM J RESP CRIT CARE, V152, P640
  14. Coalson JJ, 1999, AM J RESP CRIT CARE, V160, P1333
  15. Coalson JJ, 2006, SEMIN PERINATOL, V30, P179, DOI 10.1053/j.semperi.2006.05.004
  16. COALSON JJ, 1992, AM REV RESPIR DIS, V145, P872
  17. COALSON JJ, 1982, EXP MOL PATHOL, V37, P335, DOI 10.1016/0014-4800(82)90046-6
  18. CRAPO JD, 1980, AM REV RESPIR DIS, V122, P123
  19. Deakins KM, 2009, RESP CARE, V54, P1252
  20. DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320
  21. FRANK L, 1991, PEDIATR RES, V29, P292, DOI 10.1203/00006450-199103000-00014
  22. Guen GLC, 2008, EUR RESP J UK, V32, P1520
  23. Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC
  24. Johnson BH, 2009, PEDIATR RES, V66, P260, DOI 10.1203/PDR.0b013e3181b1bcd2
  25. Karnak I, 1999, RES EXP MED, V198, P277, DOI 10.1007/s004330050111
  26. KIKKAWA Y, 1971, AM J PATHOL, V64, P423
  27. Kovar J, 2002, J APPL PHYSIOL, V93, P629, DOI 10.1152/japplphysiol.01044.2001
  28. LUM H, 1987, J APPL PHYSIOL, V62, P1865
  29. MacRitchie AN, 2001, AM J PHYSIOL-LUNG C, V281, pL1011
  30. MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391
  31. Mascaretti RS, 2009, CLINICS, V64, P1099, DOI 10.1590/S1807-59322009001100010
  32. Mataloun Marta M G B, 2006, J Pediatr (Rio J), V82, P179, DOI 10.1590/S0021-75572006000300005
  33. Mataloun MMGB, 2009, BRAZ J MED BIOL RES, V42, P606, DOI 10.1590/S0100-879X2009000700004
  34. Moore S, 2011, JCCC HONORS J, V11
  35. NILSSON R, 1982, ACTA ANAESTH SCAND, V26, P89
  36. Okamoto C. T., 2009, Jornal Brasileiro de Patologia e Medicina Laboratorial, V45, P155, DOI 10.1590/S1676-24442009000200011
  37. Parker Thomas A, 2003, Semin Neonatol, V8, P51, DOI 10.1016/S1084-2756(02)00191-4
  38. Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452
  39. RANDELL SH, 1990, AM J PATHOL, V136, P1259
  40. Saugstad OD, 2010, J PERINAT MED, V38, P571, DOI 10.1515/JPM.2010.108
  41. Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004
  42. Speer Christian P, 2003, Semin Neonatol, V8, P29, DOI 10.1016/S1084-2756(02)00190-2
  43. Thibeault DW, 2003, PEDIATRICS, V111, P766, DOI 10.1542/peds.111.4.766
  44. Thomson MA, 2004, AM J RESP CRIT CARE, V169, P1054, DOI 10.1164/rccm.200309-1276OC
  45. THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P765
  46. Walsh MC, 2006, PEDIATRICS, V118, P1328
  47. Warner BB, 1998, AM J PHYSIOL, V275, P110
  48. Weinberger B, 2002, TOXICOL APPL PHARM, V181, P60, DOI 10.1006/taap.2002.9387
  49. Lim K, 2014, J PEDIATR-US, V164, P730, DOI 10.1016/j.jpeds.2013.11.072